AbbVie is a global, research-driven biopharmaceutical company committed to developing innovative advanced therapies for some of the world’s most complex and critical conditions. The company’s mission is to use its expertise, dedicated people and unique approach to innovation to markedly improve treatments across four primary therapeutic areas: immunology, oncology, virology and neuroscience. AbbVie is represented in Germany with headquarters in Wiesbaden and a research and manufacturing site in Ludwigshafen. In total, AbbVie Deutschland has about 2600 employees.
The Ludwigshafen site is the company's largest research and development site outside the US. Here, every step of drug development and production is carried out. Ludwigshafen is the global center of excellence for the melt extrusion (MELTREX®) technology used in the production of solid oral dosage forms with poorly soluble small molecules as active ingredients. In addition, the preclinical and clinical development of biologics represents another important core competence. Biologics are drugs that are specifically developed to emulate natural physiological substances. They exert their activity on certain cells or proteins in the body, influencing specific biological processes.
Through targeted research, modern production methods and the provision of innovative medicines, we are working toward fighting diseases and helping people to live better lives.